Product Name :
PKI (14-22) amide (myristoylated)
Sequence:
N-myristoyl-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2
Purity:
≥95% (HPLC)
Molecular Weight:
1209.5
Solubility :
Soluble to at least 1mg/ml in water.
Appearance:
Solid.
Use/Stability :
As indicated on product label or CoA when stored as recommended.
Description:
PKA inhibitor Heat-stable protein kinase inhibitor (PKI) peptide sequence (14-22). N-terminus is myristoylated to increase cell membrane permeability. The non-myristoylated version of this peptide is a highly specific inhibitor of cAMP-dependent protein kinase (PKA) with Ki=36 nM.{{27964-99-4} web|{27964-99-4} Purity & Documentation|{27964-99-4} References|{27964-99-4} manufacturer} This product is a useful tool for studying PKA in cellular systems.{{50-28-2} medchemexpress|{50-28-2} Technical Information|{50-28-2} Description|{50-28-2} manufacturer}
CAS :
201422-03-9
Solubility:
Soluble to at least 1mg/ml in water.PMID:25905163
Formula:
C53H100N20O12
Additional Information :
| Alternative Name cAMP-dependent protein kinase inhibitor (14-22) amide (myristoylated) | Appearance Solid. | CAS 201422-03-9 | Formula C53H100N20O12 | Formulation Lyophilized. Trifluoroacetate salt. | MW 1209.5 | Purity ≥95% (HPLC) | Sequence N-myristoyl-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2 | Solubility Soluble to at least 1mg/ml in water. | Source Synthetic. | Technical Info / Product Notes Replacement for ADI-HPK-108
